Showing results (131-140 of 209) with videos related to

Sort By:
Pageof 21
European Journal of Medical Research|February 5, 2000
Telemetry as a new concept in long term monitoring of SIDS-risk infantA F Aly, D Afchine, P Esser, et al.
Breast Cancer Research : BCR|November 14, 2012
The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trialHelena Linardou, Konstantine T Kalogeras, Ralf Kronenwett, et al.
Annals of Surgical Oncology|May 16, 2025
Predicting Outcomes of Breast-Conserving Surgery in Patients with Breast Cancer Using the Modified 5-Item Frailty Index: A Retrospective Cohort StudySamuel Knoedler, Jun Jiang, Philipp Moog, et al.
Translational Oncology|March 5, 2019
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent CohortsDanijel Sikic, Ralph M Wirtz, Sven Wach, et al.
Life (Basel, Switzerland)|July 2, 2021
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder CancerDanijel Sikic, Helge Taubert, Ralph M Wirtz, et al.
Urologic Oncology|July 31, 2021
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancerDanijel Sikic, Markus Eckstein, Veronika Weyerer, et al.
Clinical Breast Cancer|August 3, 2025
Prevention's Price-30-Day Outcomes of Risk-Reducing Mastectomy and Immediate Free Flap Breast ReconstructionSamuel Knoedler, Fortunay Diatta, Kevin Hu, et al.
Translational Oncology|February 26, 2018
Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder CancerM C Kriegmair, R M Wirtz, T S Worst, et al.
European Urology|March 30, 2022
Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non-muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guérin ImmunotherapyRoman Mayr, Markus Eckstein, Ralph M Wirtz, et al.
Journal of Personalized Medicine|June 2, 2021
KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder CancerHendrik Jütte, Moritz Reike, Ralph M Wirtz, et al.
Pageof 21